Literature DB >> 7857313

Involvement of NF-kappa B in the induction of NAD(P)H:quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C.

K S Yao1, P J O'Dwyer.   

Abstract

The activity of the two-electron bioreductive enzyme DT-diaphorase (DTD) is induced by heat shock, hypoxic stress, oltipraz, and mitomycin C (MMC). Transcriptional induction is associated with nuclear factor binding to elements mediating immediate early response including AP-1, though the DTD mRNA peaks at 24 hr. Electrophoretic mobility shift assays revealed that nuclear protein extracts from hypoxia-, oltipraz-, and MMC-treated cells bound a specific oligonucleotide probe corresponding to the NF-kappa B transcriptional binding site in two human cancer cell lines, HT29 and HepG2. The binding activity for the NF-kappa B site was induced with a time-course similar to that of the induction of DTD, and was delayed in comparison to the induction of AP-1 binding proteins. The time-courses of the NF-kappa B binding response to MMC, oltipraz and hypoxic treatment were similar, and binding was most pronounced at 24 hr. All three stimuli were associated with the late appearance of a higher molecular weight complex in HT29 but not in HepG2 cells, suggestive of the participation of additional rel family proteins in DNA binding in this cell line. Competition experiments indicated that the bound protein complex was specific for the NF-kappa B binding site. An immunodepletion assay showed that in each case the bound complex consisted of a heterodimer of the NF-kappa B proteins p50 and p65. These data suggest that hypoxia, oltipraz and MMC may each induce the overexpression of DTD through a mechanism involving the NF-kappa B response element in the DTD 5'-flanking region, and support a role for this element in the control of detoxication responses to environmental changes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7857313     DOI: 10.1016/0006-2952(94)00544-v

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  15 in total

Review 1.  Adaptive response to glutathione S-transferase inhibitors.

Authors:  P J Ciaccio; K D Tew
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  Identification of an N-terminal truncation of the NF-κB p65 subunit that specifically modulates ribosomal protein S3-dependent NF-κB gene expression.

Authors:  Eric M Wier; Jordan Neighoff; Xin Sun; Kai Fu; Fengyi Wan
Journal:  J Biol Chem       Date:  2012-10-31       Impact factor: 5.157

Review 3.  Pharmacodynamics and toxicodynamics of drug action: signaling in cell survival and cell death.

Authors:  A N Kong; S Mandlekar; R Yu; W Lei; A Fasanmande
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

4.  Role of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1.

Authors:  Santiago Cuevas; Yu Yang; Prasad Konkalmatt; Laureano D Asico; Jun Feranil; John Jones; Van Anthony Villar; Ines Armando; Pedro A Jose
Journal:  Hypertension       Date:  2015-04-20       Impact factor: 10.190

5.  Phase 0 of the Xenobiotic Response: Nuclear Receptors and Other Transcription Factors as a First Step in Protection from Xenobiotics.

Authors:  William S Baldwin
Journal:  Nucl Receptor Res       Date:  2019-11-20

6.  Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.

Authors:  P J O'Dwyer; C E Szarka; K S Yao; T C Halbherr; G R Pfeiffer; F Green; J M Gallo; J Brennan; H Frucht; E B Goosenberg; T C Hamilton; S Litwin; A M Balshem; P F Engstrom; M L Clapper
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

7.  Transcription regulation of rat glutathione S-transferase Ya subunit gene expression by chemopreventive agents.

Authors:  P Fei; G A Matwyshyn; T H Rushmore; A N Kong
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

8.  Delayed Nrf2-regulated antioxidant gene induction in response to silica nanoparticles.

Authors:  Hongqiao Zhang; Lulu Zhou; Jenay Yuen; Nancy Birkner; Valerie Leppert; Peggy A O'Day; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2017-04-04       Impact factor: 7.376

Review 9.  The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy.

Authors:  G U Dachs; I J Stratford
Journal:  Br J Cancer Suppl       Date:  1996-07

10.  Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes.

Authors:  Stuart A Rushworth; David J MacEwan; Maria A O'Connell
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.